Skip to main content
Equibles
IMVT logo

IMVT · Immunovant, Inc. · Webcasts, Transcripts & Audio

Track IMVT — free

Use IMVT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMVT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$34.18 -0.87 (-2.48%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$7.07B
Shares
206.95M
Volume · Nov 13 864.88K Avg daily vol (3M) 1.43M

Immunovant, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Immunovant, Inc. (IMVT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

Embed Immunovant, Inc. earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    


    
    

        

            
            
            
            
        

            

                
                    
                    
                    
                    
                    
                    
            

        
        
    


    
    

            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY27 · Q2

                    
2026-11-09

                


                
                

                    
Immunovant, Inc. (IMVT) Q2 2027 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Diluted EPS

                                    
$-0.47

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY27 · Q1

                    
2026-08-06

                


                
                

                    
Immunovant, Inc. (IMVT) Q1 2027 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Diluted EPS

                                    
$-0.75

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY26 · Q4

                    
2026-05-20

                


                
                

                    
Immunovant, Inc. (IMVT) Q4 2026 Earnings Call

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY26 · Q3

                    
2026-02-06

                


                
                

                    
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                Thyroid Eye Disease (TED)
                                BREPO Phase 2 in Cutaneous Sarcoidosis
                                Graves' Disease / Competitive Landscape
                    

                


                
                

                        

                                

                                    
Diluted EPS

                                    
$-0.61

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY26 · Q2

                    
2025-11-10

                


                
                

                    
Immunovant, Inc. (IMVT) Q2 2026 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                Competitive landscape in TED and myositis
                                Batoclimab and IMVT-1402 in Graves' disease
                                Brepocitinib VALOR Phase 3 data in dermatomyositis
                    

                


                
                

                        

                                

                                    
Diluted EPS

                                    
$-0.73

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY25 · Q2

                    
2024-11-07

                


                
                

                    
Immunovant, Inc. (IMVT) Q2 2025 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                Competitive landscape in Graves' and TED
                                Batoclimab and IMVT-1402 in Graves' disease
                                Catalyst roadmap and upcoming readouts
                    

                


                
                

                        

                                

                                    
Diluted EPS

                                    
$-0.74

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q1

                    
2022-08-05

                


                
                

                    
Immunovant, Inc. (IMVT) Q1 2023 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Diluted EPS

                                    
$-0.35

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q4

                    
2022-06-08

                


                
                

                    
Immunovant, Inc. (IMVT) Q4 2022 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q1

                    
2021-08-09

                


                
                

                    
Immunovant, Inc. (IMVT) Q1 2022 Earnings Call Transcript

                    

                    

                


                
                

                        

                                

                                    
Diluted EPS

                                    
$-0.31

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY21 · Q4

                    
2021-06-01

                


                
                

                    
Immunovant, Inc. (IMVT) Q4 2021 Earnings Call

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
    

    

        
Showing 1–10 of 10 webcasts

    

    

    
    


        

    

        

            

                Key facts
                    
                        CIK
                        1764013
                    
                    
                        CUSIP
                        45258J102
                    
                    
                        13F (30d)
                        171 filings
                        156 filers
                    
                    
                    
                         Visit website
                        
                    
                    
                         Investor relations